Skip to content
triangle-white-good

FEATURED ARTICLE

Inteliquet Achieves Milestone in Modernizing Patient Recruitment For Clinical Trials: 250 Digitized Trials Enabling 1000 Patients to be Identified for Clinical Trials

FEATURED ARTICLE

Inteliquet Achieves Milestone in Modernizing Patient Recruitment For Clinical Trials: 250 Digitized Trials Enabling 1000 Patients to be Identified for Clinical Trials

VIEW BY
second-menu-section

NEWS PAGE

24 July, 2019

From Managed Healthcare Executive: “We Need a Better Clinical Trial Recruitment Process”

CEO Carla Balch notes that"being data-driven isn't enough to improve the scale and precision of clinical trials." Find out why.
READ MORE

15 July, 2019

ASCO 2019: CEO Carla Balch Discusses How to Achieve Clinical Trial Success

At ASCO 2019, CEO Carla Balch sat down with Oncology Central. She discussed how Inteliquet brings "one source of truth" to the stakeholders of clinical trial process, including Pharma, CROs, patients, and providers.
READ MORE

07 June, 2019

From Biocentury.com: ASCO 2019 sessions provide guidance on expanding patient pools for clinical trials

Staff Writer Allison Johnson speaks to CEO Carla Balch about how drug developers can match more patients to clinical trials by broadening eligibility criteria and encouraging trial enrollment in community settings.
READ MORE

20 May, 2019

From genomeweb.com: Newly Rebranded Inteliquet Bolstering Precision Oncology Offerings Through NCI Contract

READ MORE

20 May, 2019

Press Release: Inteliquet Signs Cooperative R&D Agreement (CRADA) with the National Cancer Institute

Inteliquet announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Health and Human Services, as represented by the National Cancer Institute (NCI). The principal goal of this research agreement is to develop a clinic-ready, web-based tool, using NCI’s Oncogenomics browser with Inteliquet’s proprietary Precision Medicine Platform to aid clinicians in therapeutic decision-making.
READ MORE

INTELIQUET MEDIA CONTACT

Chris Gale, Vice President

Greentarget Global Group

Phone: 646-695-2883

Email: cgale@greentarget.com

LEARN MORE

Would you like a demo? More information? Let us know how we can help. We’ll contact you shortly.